ARTICLE | Politics, Policy & Law
A clear understanding of threats and opportunities will be essential as the biopharma industry steps into the second Trump administration
By Steve Usdin, Washington Editor
November 23, 2024 3:24 AM UTC
Nothing has changed in Washington, but two months ahead of inauguration day, it already feels as if everything is different. Biopharma leaders believe there is an urgent need to seize the opportunities and head off threats posed by the incoming administration.
A consensus has emerged among pharmaceutical and biotech CEOs who are trying to plot a course through the transition and into the new Congress and administration. They are looking for areas of common ground with President-elect Donald Trump and his nominees for critical positions, hoping to steer clear of conflict, and sketching out red lines that would lead them to go on the offensive. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654295/trump-2-0-presents-opportunities-threats